The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Sava, Francesco ^a   Laviolette, Louis ^a   Bernard, Sarah ^a   Breton, Marie Josée ^b   Bourbeau, Jean ^b   Maltais, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYCLING; DISEASE SEVERITY; ENDURANCE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; WALKING; DYSPNEA; ERGOMETRY; EXERCISE; LUNG VENTILATION; LUNG VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIROMETRY; TREATMENT OUTCOME;

AGED; BODY MASS INDEX; DYSPNEA; ERGOMETRY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PHYSICAL EXERTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; QUALITY OF LIFE; SPIROMETRY; TREATMENT OUTCOME; WALKING;

EID: 78049381527     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-55     Document Type: Article

References (50)

1. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1791-1797.
2. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158:629-634.
3. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis 2008, 5:205-209. 10.1177/1479972308096711, 19029231.
4. Celli BR, Cote CG, Marin JM, Casanova C, Montes de OM, Mendez RA, Pinto PV, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012. 10.1056/NEJMoa021322, 14999112.
5. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 1997, 111:891-898. 10.1378/chest.111.4.891, 9106566.
6. Salvadori A, Fanari P, Mazza P, Agosti R, Longhini E. Work capacity and cardiopulmonary adaptation of the obese subject during exercise testing. Chest 1992, 101:674-679. 10.1378/chest.101.3.674, 1541131.
7. Swinburn CR, Cooper BG, Mould H, Corris PA, Gibson GJ. Adverse effect of additional weight on exercise against gravity in patients with chronic obstructive airways disease. Thorax 1989, 44:716-720. 10.1136/thx.44.9.716, 462051, 2588207.
8. Jia H, Lubetkin EI. The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf) 2005, 27:156-164. 10.1093/pubmed/fdi025, 15820993.
9. Han TS, Tijhuis MA, Lean ME, Seidell JC. Quality of life in relation to overweight and body fat distribution. Am J Public Health 1998, 88:1814-1820. 10.2105/AJPH.88.12.1814, 1509048, 9842379.
10. Al SS, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS. The effect of obesity on disability vs mortality in older Americans. Arch Intern Med 2007, 167:774-780. 10.1001/archinte.167.8.774, 17452539.
11. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE. Combined Effects of Obesity and COPD on Dyspnea and Exercise Tolerance. Am J Respir Crit Care Med 2009, 180(10):964-71.
12. Laviolette L, Sava F, O'Donnell DE, Webb KA, Hamilton AL, Kesten S, Maltais F. Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med 2010, 10:33. 10.1186/1471-2466-10-33, 2891696, 20509967.
13. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 2007, 43:475-485.
14. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1856-1861.
15. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, Hernandez P, Rouleau M, Julien M, Parenteau S, Paradis B, Levy RD, Camp P, Lecours R, Audet R, Hutton B, Penrod JR, Picard D, Bernard S. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008, 149:869-878.
16. Laviolette L, Bourbeau J, Bernard S, Lacasse Y, Pepin V, Breton MJ, Baltzan M, Rouleau M, Maltais F. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 2008, 63:115-121. 10.1136/thx.2006.076844, 17901158.
17. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959, 2:257-266. 10.1136/bmj.2.5147.257, 1990153, 13823475.
18. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 1998, 6(Suppl 2):51S-209S.
19. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
20. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993, 16:5-40.
21. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van WC, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545.
22. Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NL, Fallen EL, Taylor DW. Effect of encouragement on walking test performance. Thorax 1984, 39:818-822. 10.1136/thx.39.11.818, 459930, 6505988.
23. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002, 166:111-117.
24. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997, 155:1278-1282.
25. Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients. Respir Med 2001, 95:618-626. 10.1053/rmed.2001.1115, 11453321.
26. Bourbeau J, Maltais F, Rouleau M, Guimont C. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease. Can Respir J 2004, 11:480-486.
27. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
28. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005, 2:75-79. 10.1081/COPD-200050513, 17136966.
29. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005, 2:105-110. 10.1081/COPD-200050655, 17136970.
30. Bernard S, Whittom F, Leblanc P, Jobin J, Belleau R, Berube C, Carrier G, Maltais F. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:896-901.
31. Tjepkema M. Nutrition: Findings from the Canadian Community Health Survey. Statistics Canada Catalog 2005,
32. Eisner MD, Blanc PD, Sidney S, Yelin EH, Lathon PV, Katz PP, Tolstykh I, Ackerson L, Iribarren C. Body composition and functional limitation in COPD. Respir Res 2007, 8:7. 10.1186/1465-9921-8-7, 1797017, 17261190.
33. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 2006, 15:84-91. 10.1016/j.pcrj.2005.09.001, 16701766.
34. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J Suppl 2003, 46:81s-86s. 10.1183/09031936.03.00004611, 14621110.
35. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sorensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006, 173:79-83. 10.1164/rccm.200505-969OC, 16368793.
36. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002, 162:1477-1481. 10.1001/archinte.162.13.1477, 12090884.
37. Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008, 178:332-338. 10.1164/rccm.200712-1869OC, 18511702.
38. Ofir D, Laveneziana P, Webb KA, O'Donnell DE. Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol 2007, 102:2217-2226. 10.1152/japplphysiol.00898.2006, 17234804.
39. Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005, 26:630-636. 10.1183/09031936.05.00045505, 16204593.
40. Garrow JS, Summerbell CD. Meta-analysis: effect of exercise, with or without dieting, on the body composition of overweight subjects. Eur J Clin Nutr 1995, 49:1-10.
41. Crisafulli E, Costi S, Luppi F, Cirelli G, Cilione C, Coletti O, Fabbri LM, Clini EM. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008, 63:487-492. 10.1136/thx.2007.086371, 18203818.
42. Crisafulli E, Gorgone P, Vagaggini B, Pagani M, Rossi G, Costa F, Guarriello V, Paggiaro P, Chetta A, de BF, Olivieri D, Fabbri LM, Clini EM. Efficacy of standard rehabilitation in COPD outpatients with co-morbidities. Eur Respir J 2010, 36(5):1042-8. 10.1183/09031936.00203809, 20413540.
43. Riario-Sforza GG, Incorvaia C, Paterniti F, Pessina L, Caligiuri R, Pravettoni C, Di MF, Centanni S. Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study. Int J Chron Obstruct Pulmon Dis 2009, 4:315-319. 2740953, 19750191.
44. Leung RW, Alison JA, McKeough ZJ, Peters MJ. Ground walk training improves functional exercise capacity more than cycle training in people with chronic obstructive pulmonary disease (COPD): a randomised trial. J Physiother 2010, 56:105-112.
45. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000, 71:733-738.
46. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997, 10:2807-2813. 10.1183/09031936.97.10122807, 9493665.
47. Marquis K, Debigare R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:809-813. 10.1164/rccm.2107031, 12231489.
48. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005, 82:53-59.
49. Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995, 152:1268-1274.
50. Takigawa N, Tada A, Soda R, Takahashi S, Kawata N, Shibayama T, Matsumoto H, Hamada N, Hirano A, Kimura G, Okada C, Endo S, Yamashita M, Date H, Takahashi K. Comprehensive pulmonary rehabilitation according to severity of COPD. Respir Med 2007, 101:326-332. 10.1016/j.rmed.2006.03.044, 16824743.